Abstract
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained interested in recent years, enabling personalisation of medicines. It also facilitates advanced control of the micro-structure of the tablet core, permitting fine tuning of product release characteristics with a single formulation. In addition, the technology also offers a platform for Dose escalation studies employing a single formulation and single manufacturing step. The objective of this study was to develop a printability map of pharmaceutically relevant feedstock material for FDM.
| Original language | English |
|---|---|
| Number of pages | 1 |
| Publication status | Published - 7 Sept 2021 |
| Event | Virtual PharmSci : APS international conference - Duration: 7 Sept 2021 → 9 Sept 2021 https://www.apsgb.co.uk/event/virtual-aps-pharmsci-2021/#:~:text=Overview,%2C8th%20%26%209th%20September%202021.&text=Presentations%20on%20'Pharmaceutical%20Sciences%20and,Global%20COVID%2D19%20Pandemic'. |
Conference
| Conference | Virtual PharmSci |
|---|---|
| Period | 7/09/21 → 9/09/21 |
| Internet address |
Keywords
- 3D Printing
- pharmaceutical formulations
- mechanical testing
- rheology screening
- FDM (Fused Deposition Modeling)